These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18444920)

  • 41. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
    Lablanche S; Vantyghem MC; Kessler L; Wojtusciszyn A; Borot S; Thivolet C; Girerd S; Bosco D; Bosson JL; Colin C; Tetaz R; Logerot S; Kerr-Conte J; Renard E; Penfornis A; Morelon E; Buron F; Skaare K; Grguric G; Camillo-Brault C; Egelhofer H; Benomar K; Badet L; Berney T; Pattou F; Benhamou PY;
    Lancet Diabetes Endocrinol; 2018 Jul; 6(7):527-537. PubMed ID: 29776895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin independence following isolated islet transplantation and single islet infusions.
    Markmann JF; Deng S; Huang X; Desai NM; Velidedeoglu EH; Lui C; Frank A; Markmann E; Palanjian M; Brayman K; Wolf B; Bell E; Vitamaniuk M; Doliba N; Matschinsky F; Barker CF; Naji A
    Ann Surg; 2003 Jun; 237(6):741-9; discussion 749-50. PubMed ID: 12796569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.
    Hirshberg B; Mog S; Patterson N; Leconte J; Harlan DM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5424-9. PubMed ID: 12466330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
    Toso C; Morel P; Bucher P; Mathe Z; Demuylder-Mischler S; Bosco D; Berney T; Oberholzer J; Shapiro J; Oberholzer J; Philippe J
    Transplantation; 2003 Oct; 76(7):1133-4. PubMed ID: 14557767
    [No Abstract]   [Full Text] [Related]  

  • 45. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
    Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL
    Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.
    O'Connell PJ; Holmes-Walker DJ; Goodman D; Hawthorne WJ; Loudovaris T; Gunton JE; Thomas HE; Grey ST; Drogemuller CJ; Ward GM; Torpy DJ; Coates PT; Kay TW;
    Am J Transplant; 2013 Jul; 13(7):1850-8. PubMed ID: 23668890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of add-on exenatide to insulin on glycemic variability and hypoglycemia in patients with type 1 diabetes mellitus.
    Jiang LL; Wang SQ; Ding B; Zhu J; Jing T; Ye L; Lee KO; Wu JD; Ma JH
    J Endocrinol Invest; 2018 May; 41(5):539-547. PubMed ID: 29032494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancreas-After-Islet Transplantation in Nonuremic Type 1 Diabetes: A Strategy for Restoring Durable Insulin Independence.
    Wisel SA; Gardner JM; Roll GR; Harbell J; Freise CE; Feng S; Kang SM; Hirose R; Kaufman DB; Posselt AM; Stock PG
    Am J Transplant; 2017 Sep; 17(9):2444-2450. PubMed ID: 28489277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Islet cell transplantation.
    Vaithilingam V; Sundaram G; Tuch BE
    Curr Opin Organ Transplant; 2008 Dec; 13(6):633-8. PubMed ID: 19060555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial.
    Badet L; Benhamou PY; Wojtusciszyn A; Baertschiger R; Milliat-Guittard L; Kessler L; Penfornis A; Thivolet C; Renard E; Bosco D; Morel P; Morelon E; Bayle F; Colin C; Berney T;
    Transplantation; 2007 Jul; 84(1):89-96. PubMed ID: 17627243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study.
    Mastrandrea L; Yu J; Behrens T; Buchlis J; Albini C; Fourtner S; Quattrin T
    Diabetes Care; 2009 Jul; 32(7):1244-9. PubMed ID: 19366957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.
    Bergenstal R; Lewin A; Bailey T; Chang D; Gylvin T; Roberts V;
    Curr Med Res Opin; 2009 Jan; 25(1):65-75. PubMed ID: 19210140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful islet transplantation from the pancreata of non-heart-beating donors.
    Kenmochi T; Maruyama M; Saigo K; Akutsu N; Iwashita C; Otsuki K; Ito T; Suzuki A; Miyazaki M; Saito T
    Transplant Proc; 2008 Oct; 40(8):2568-70. PubMed ID: 18929803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical study of the month. Prolonged insulin independence after transplantation of islets of Langerhans in a patient with type 1 diabetes: achievement of a dream?].
    Scheen AJ
    Rev Med Liege; 2000 Aug; 55(8):803-5. PubMed ID: 11051779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Islet transplantation in patients with diabetes mellitus: choice of immunosuppression.
    Nanji SA; Shapiro AM
    BioDrugs; 2004; 18(5):315-28. PubMed ID: 15377174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
    Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
    Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients.
    Balke EM; Demeester S; Lee D; Gillard P; Hilbrands R; Van de Velde U; Van der Auwera BJ; Ling Z; Roep BO; Pipeleers DG; Keymeulen B; Gorus FK
    Diabetologia; 2018 Jul; 61(7):1623-1632. PubMed ID: 29679103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcomes of clinical transplantation of pancreatic islets with uncontrolled donors after cardiac death: a multicenter experience in Japan.
    Anazawa T; Saito T; Goto M; Kenmochi T; Uemoto S; Itoh T; Yasunami Y; Kenjo A; Kimura T; Ise K; Tsuchiya T; Gotoh M
    Transplant Proc; 2014; 46(6):1980-4. PubMed ID: 25131088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.
    Nijhoff MF; Engelse MA; Dubbeld J; Braat AE; Ringers J; Roelen DL; van Erkel AR; Spijker HS; Bouwsma H; van der Boog PJ; de Fijter JW; Rabelink TJ; de Koning EJ
    Am J Transplant; 2016 Jan; 16(1):246-53. PubMed ID: 26288226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.